Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 2.4.1.18 - 1,4-alpha-glucan branching enzyme

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
1,4-alpha-glucan branching enzyme deficiency
A new variant of type IV glycogenosis with primary cardiac manifestation and complete branching enzyme deficiency. In vivo detection by heart muscle biopsy.
A new variant of type IV glycogenosis: deficiency of branching enzyme activity without apparent progressive liver disease.
A novel mouse model that recapitulates adult-onset glycogenosis type 4.
Acute but transient neurological deterioration revealing adult polyglucosan body disease.
Adult polyglucosan body disease: a rare presentation with chronic liver disease and ground-glass hepatocellular inclusions.
Allele frequency and likely impact of the glycogen branching enzyme deficiency gene in Quarter Horse and Paint Horse populations.
Alteration of mitochondrial function in the livers of mice with glycogen branching enzyme deficiency.
Amylopectinosis disease isolated to the heart with normal glycogen branching enzyme activity and gene sequence.
Apparent absence of glycogen branching enzyme activity in phosphofructokinase deficiency.
Branching enzyme activity of cultured amniocytes and chorionic villi: prenatal testing for type IV glycogen storage disease.
Branching enzyme deficiency/glycogenosis storage disease type IV presenting as a severe congenital hypotonia: Muscle biopsy and autopsy findings, biochemical and molecular genetic studies.
Branching enzyme deficiency: expanding the clinical spectrum.
Characterization of the endosperm starch and the pleiotropic effects of biosynthetic enzymes on their properties in novel mutant rice lines with high resistant starch and amylose content.
Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV).
Congenital type IV glycogenosis: the spectrum of pleomorphic polyglucosan bodies in muscle, nerve, and spinal cord with two novel mutations in the GBE1 gene.
Deficiencies in both starch synthase IIIa and branching enzyme IIb lead to a significant increase in amylose in SSIIa-inactive japonica rice seeds.
Efficient correction of a deleterious point mutation in primary horse fibroblasts with CRISPR-Cas9.
Equine diseases caused by known genetic mutations.
Evaluation of allele frequencies of inherited disease genes in subgroups of American Quarter Horses.
Generation of a novel mouse model that recapitulates early and adult onset glycogenosis type IV.
Glycogen branching enzyme deficiency in adult polyglucosan body disease.
Glycogen branching enzyme deficiency in an infant with severe congenital hypotonia: an emerging diagnosis of muscle weakness in the perinatal period.
Glycogen branching enzyme deficiency in quarter horse foals.
Glycogen storage disease type IV: inherited deficiency of branching enzyme activity in cats.
Hallmarks of oxidative stress in the livers of aged mice with mild glycogen branching enzyme deficiency.
Isolation of human glycogen branching enzyme cDNAs by screening complementation in yeast.
Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).
Maize starch-branching enzyme isoforms and amylopectin structure. In the absence of starch-branching enzyme IIb, the further absence of starch-branching enzyme Ia leads to increased branching.
Multisystem involvement in a patient due to accumulation of amylopectin-like material with diminished branching enzyme activity.
Neuromuscular forms of glycogen branching enzyme deficiency.
Null mutations and lethal congenital form of glycogen storage disease type IV.
Polyglucosan neurotoxicity caused by glycogen branching enzyme deficiency can be reversed by inhibition of glycogen synthase.
Progress and problems in muscle glycogenoses.
Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency.
Severe cardiopathy in branching enzyme deficiency.
SGK1 (glucose transport), dishevelled2 (wnt signaling), LC3/p62 (autophagy) and p53 (apoptosis) proteins are unaltered in Lafora disease.
Structural basis of glycogen branching enzyme deficiency and pharmacologic rescue by rational peptide design.
The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies.
Type IV glycogen storage disease: branching enzyme deficiency in skin fibroblasts and possible heterozygote detection.
[Adult polyglucosan antibody disease. Case report with predominant involvement of the central and peripheral nervous system and branching enzyme defect in leukocytes]
[Glycogen branching enzyme deficiency (Andersen disease)]
[Polysaccharide amylopectin-type storage myopathy]
[Severe cardiomyopathy revealing amylopectinosis. Two cases in adolescents from the same family]
6-phosphofructokinase deficiency
Apparent absence of glycogen branching enzyme activity in phosphofructokinase deficiency.
[Polysaccharide amylopectin-type storage myopathy]
Acute Kidney Injury
Ginaton injection alleviates cisplatin-induced renal interstitial fibrosis in rats via inhibition of apoptosis through regulation of the p38MAPK/TGF-?1 and p38MAPK/HIF-1? pathways.
Adenocarcinoma of Lung
Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma.
Adenoma
Essential role of constitutive androstane receptor in Ginkgo biloba extract induced liver hypertrophy and hepatocarcinogenesis.
Albuminuria
Nrf-2 mediated heme oxygenase-1 activation contributes to the anti-inflammatory and renal protective effects of Ginkgo biloba extract in diabetic nephropathy.
Alzheimer Disease
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia.
Mixing Ginkgo biloba Extract with Sesame Extract and Turmeric Oil Increases Bioavailability of Ginkgolide A in Mice Brain.
Amnesia
Effects of ginkgo biloba extract on impairment of learning induced by cerebral ischemia in mice.
amp deaminase deficiency
[Diagnostic significance of muscle biopsies in metabolic myopathies. II. Clinical biochemistry]
Anaphylaxis
Antiallergic and Antiarthritic Effects of Stem Bark Extract of Glyphaea brevis (Spreng) Monachino (Tiliaceae) in Murine Models.
Histochemical investigations on phosphorylase, branching enzyme and glycogen in guinea pig livers in experimental anaphylactic and histaminic shock.
Angina Pectoris
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia.
Aortic Rupture
Ginkgo biloba extracts prevent aortic rupture in angiotensin II-infused hypercholesterolemic mice.
Arrhythmias, Cardiac
Effect of Ginkgo biloba extract on pacemaker channels encoded by HCN gene.
[Protection effect of Yindan Xinnaotong capsule and main compositions compatibility on myocardial ischemia/reperfusion injury].
Arthritis
Antiallergic and Antiarthritic Effects of Stem Bark Extract of Glyphaea brevis (Spreng) Monachino (Tiliaceae) in Murine Models.
Asthma
Herb-drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats.
The effect of Ginkgo Biloba extract on the expression of PKCalpha in the inflammatory cells and the level of IL-5 in induced sputum of asthmatic patients.
[Studies on the effect of Ginkgo biloba extracts on NF-kappaB pathway]
Ataxia
Role of inhibiting Chk1-p53 pathway in hepatotoxicity caused by chronic arsenic exposure from coal-burning.
Atherosclerosis
Ginkgo biloba extract inhibits tumor necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells.
Ginkgo biloba extract reduces high-glucose-induced endothelial reactive oxygen species generation and cell adhesion molecule expression by enhancing HO-1 expression via Akt/eNOS and p38 MAP kinase pathways.
Ginkgo biloba inhibits hydrogen peroxide-induced activation of nuclear factor kappa B in vascular endothelial cells.
Ginkgo Biloba Leaf Extract Attenuates Atherosclerosis in Streptozotocin-Induced Diabetic ApoE-/- Mice by Inhibiting Endoplasmic Reticulum Stress via Restoration of Autophagy through the mTOR Signaling Pathway.
Ginkgo bilobaExtract(GbE) Enhances the Anti-atherogenic Effect of Cilostazol by InhibitingROS Generation.
Blister
Elective surgery for giant bullous emphysema: a 5-year clinical and functional follow-up.
[Current trends in in the treatment of spontaneous pneumothorax]
Bradycardia
Long-term feeding of Ginkgo biloba extract impairs peripheral circulation and hepatic function in aged spontaneously hypertensive rats.
Brain Edema
Ginkgo biloba extract facilitates recovery from penetrating brain injury in adult male rats.
Brain Injuries
Effects of gingko biloba extract on glutamate-induced [Ca2+]i changes in cultured cortical astrocytes after hypoxia/reoxygenation, H2O2 or L-glutamate injury.
Ginkgolide B promotes neuronal differentiation through the Wnt/?-catenin pathway in neural stem cells of the postnatal mammalian subventricular zone.
Brain Ischemia
Effect of Ginkgo biloba leaf extract on electroencephalography of rat with cerebral ischemia and reperfusion.
Effects of Ginkgo biloba extract on acute cerebral ischemia in rats analyzed by magnetic resonance spectroscopy.
[Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof]
Breast Neoplasms
Antiestrogenic activities of Ginkgo biloba extracts.
Chemopreventive effects of Ginkgo biloba extract in estrogen-negative human breast cancer cells.
Carcinogenesis
Hepatocellular Carcinomas in B6C3F1 Mice Treated with Ginkgo biloba Extract for Two Years Differ from Spontaneous Liver Tumors in Cancer Gene Mutations and Genomic Pathways.
Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.
Carcinoma
Histochemical studies of glycogen metabolizing enzymes in normal and abnormal human cervical epithelium.
[Experimental studies of the protective effect of ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats]
Carcinoma in Situ
Histochemical studies of glycogen metabolizing enzymes in normal and abnormal human cervical epithelium.
Carcinoma, Hepatocellular
Hepatocellular Carcinomas in B6C3F1 Mice Treated with Ginkgo biloba Extract for Two Years Differ from Spontaneous Liver Tumors in Cancer Gene Mutations and Genomic Pathways.
Isolation of human glycogen branching enzyme cDNAs by screening complementation in yeast.
Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.
Carcinoma, Squamous Cell
[Experimental studies of the protective effect of ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats]
Cardiomegaly
Cardioprotective Action of Ginkgo biloba Extract against Sustained ?-Adrenergic Stimulation Occurs via Activation of M2/NO Pathway.
Cardiomyopathies
Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).
Severe cardiopathy in branching enzyme deficiency.
Cardiomyopathy, Dilated
Neonatal hypotonia and cardiomyopathy secondary to type IV glycogenosis.
Cardiovascular Diseases
Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases.
Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications.
Catalepsy
Antiallergic and Antiarthritic Effects of Stem Bark Extract of Glyphaea brevis (Spreng) Monachino (Tiliaceae) in Murine Models.
Cataract
Antidiabetic cataract effects of GbE, rutin and quercetin are mediated by the inhibition of oxidative stress and polyol pathway.
Ginkgo biloba extract prevents against apoptosis induced by high glucose in human lens epithelial cells.
Cerebral Infarction
Ginkgo biloba extract protects diabetic rats against cerebral ischemia?reperfusion injury by suppressing oxidative stress and upregulating the expression of glutamate transporter 1.
Injections of ginkgo in the treatment of cerebral infarction: a systematic review and network Meta-analysis.
Mechanisms Associated with Protective Effects of Ginkgo Biloba Leaf Extracton in Rat Cerebral Ischemia Reperfusion Injury.
[Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof]
Cholelithiasis
Identification and replication of six new loci associated with gallstone disease.
Colitis, Ischemic
Therapeutic effects of Ginkgo biloba extract against acute ischemic colitis.
Colonic Neoplasms
Antioxidant and antigenotoxic activities of Ginkgo biloba L. leaf extract are retained after in vitro gastrointestinal digestive conditions.
Colorectal Neoplasms
Phase II study of combined 5-fluorouracil/ Ginkgo biloba extract (GBE 761 ONC) therapy in 5-fluorouracil pretreated patients with advanced colorectal cancer.
Congenital Abnormalities
Effects of Ginkgo biloba extract on the embryo-fetal development in Wistar rats.
Coronary Artery Disease
Ginkgo biloba extract improves coronary blood flow in patients with coronary artery disease: role of endothelium-dependent vasodilation.
Coronary Disease
[Change of peripheral blood monocytes derived macrophage scavenger receptors activity in patients with coronary heart disease, and the intervention effect of ginkgo biloba extract]
Craniocerebral Trauma
[Myocardial damage and change of mitochondrial Mn-superoxide dismutase activity in craniocerebral injured rats and the interventing effect of ginkgo biloba extract]
Dehydration
Biosynthesis, structure and functionality of starch granules in maize inbred lines with different kernel dehydration rate.
Dementia
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline.
A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.
Effectiveness of standardized ginkgo biloba extract on cognitive symptoms of dementia with a six-month treatment: a bivariate random effect meta-analysis.
Effects of Ginkgo biloba on dementia: An overview of systematic reviews.
Ginkgo Biloba Extract Consumption and Long-Term Occurrence of Death and Dementia.
Mixing Ginkgo biloba Extract with Sesame Extract and Turmeric Oil Increases Bioavailability of Ginkgolide A in Mice Brain.
Patterns of dietary supplement usage in demographically diverse older people.
Diabetes Mellitus
Ethanolic Ginkgo biloba leaf extract prevents renal fibrosis through Akt/mTOR signaling in diabetic nephropathy.
New Insight into the Mechanisms of Ginkgo Biloba Extract in Vascular Aging Prevention.
The effects of Ginkgo biloba extract (GBe) on axonal transport microvasculature and morphology of sciatic nerve in streptozotocin-induced diabetic rats.
Diabetes Mellitus, Type 2
Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake.
Diabetic Angiopathies
Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications.
Diabetic Nephropathies
Ethanolic Ginkgo biloba leaf extract prevents renal fibrosis through Akt/mTOR signaling in diabetic nephropathy.
Protective effects of serum containing Ginkgo biloba extract on glomerulosclerosis in rat mesangial cells.
Dry Eye Syndromes
Effects of Lycium barbarum (goji berry) on dry eye disease in rats.
Dyslipidemias
Beneficial effects of Ginkgo biloba extract on insulin signaling cascade, dyslipidemia, and body adiposity of diet-induced obese rats.
Epidermolysis Bullosa, Junctional
Equine diseases caused by known genetic mutations.
Epilepsies, Myoclonic
Glycogen branching enzyme in Lafora myoclonus epilepsy.
Erythema
[Changes of nitric oxide after trichloroethylene irritation in hairless mice skin and protection of ginkgo biloba extract and vitamin E]
Gastrointestinal Hemorrhage
Therapeutic effects of Ginkgo biloba extract against acute ischemic colitis.
Genetic Diseases, Inborn
Equine diseases caused by known genetic mutations.
Non-lethal congenital hypotonia due to glycogen storage disease type IV.
[Severe cardiomyopathy revealing amylopectinosis. Two cases in adolescents from the same family]
Glaucoma
Complementary therapy for the treatment of glaucoma: a perspective.
Ginkgo biloba and its potential role in glaucoma.
Ginkgo biloba Extract and Bilberry Anthocyanins Improve Visual Function in Patients with Normal Tension Glaucoma.
The association between self-reported glaucoma and ginkgo biloba use.
glucan 1,4-alpha-glucosidase deficiency
Glycogen storage diseases of muscle.
glycogen phosphorylase deficiency
Glycogen storage diseases of muscle.
Glycogen Storage Disease
A case of congenital glycogen storage disease type IV with a novel GBE1 mutation.
A Case of Glycogen Storage Disease IV with Rare Homozygous Mutations in the Glycogen Branching Enzyme Gene.
A complex rearrangement in GBE1 causes both perinatal hypoglycemic collapse and late-juvenile-onset neuromuscular degeneration in glycogen storage disease type IV of Norwegian forest cats.
A GYS1 gene mutation is highly associated with polysaccharide storage myopathy in Cob Normand draught horses.
A Modified Enzymatic Method for Measurement of Glycogen Content in Glycogen Storage Disease Type IV.
A new variant of type IV glycogenosis with primary cardiac manifestation and complete branching enzyme deficiency. In vivo detection by heart muscle biopsy.
A new variant of type IV glycogenosis: deficiency of branching enzyme activity without apparent progressive liver disease.
A novel missense mutation in the glycogen branching enzyme gene in a child with myopathy and hepatopathy.
Alteration of mitochondrial function in the livers of mice with glycogen branching enzyme deficiency.
Association of the Congenital Neuromuscular Form of Glycogen Storage Disease Type IV With a Large Deletion and Recurrent Frameshift Mutation.
Branching enzyme activity of cultured amniocytes and chorionic villi: prenatal testing for type IV glycogen storage disease.
Branching enzyme in erythrocytes. Detection of type IV glycogenosis homozygotes and heterozygotes.
Cardiac Involvement in Glycogen Storage Disease Type IV: Two Cases and the Two Ends of a Spectrum.
Case of Neonatal Fatality from Neuromuscular Variant of Glycogen Storage Disease Type IV.
Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV).
Concomitant branching enzyme and phosphorylase deficiencies. An unusual glycogenosis with extensive neuronal polyglucosan storage.
Fatal infantile neuromuscular presentation of glycogen storage disease type IV.
Generation of a novel mouse model that recapitulates early and adult onset glycogenosis type IV.
Genetic mapping of GBE1 and its association with glycogen storage disease IV in American Quarter horses.
Glycogen branching enzyme (GBE1) mutation causing equine glycogen storage disease IV.
Glycogen storage disease type IV: a case report.
Glycogen storage disease type IV: inherited deficiency of branching enzyme activity in cats.
Glycogen storage disease type IV: novel mutations and molecular characterization of a heterogeneous disorder.
Glycogen storage diseases of muscle.
Immunohistochemical and ultrastructural changes in the brain in probable adult glycogenosis type IV: adult polyglucosan body disease.
Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).
Living Donor Liver Transplantation in a Korean Child with Glycogen Storage Disease Type IV and a GBE1 Mutation.
Neonatal type IV glycogen storage disease associated with "null" mutations in glycogen branching enzyme 1.
Neuromuscular forms of glycogen branching enzyme deficiency.
Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 gene.
Non-lethal congenital hypotonia due to glycogen storage disease type IV.
Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease.
Placental Involvement in Glycogen Storage Disease Type IV.
Polyglucosan neurotoxicity caused by glycogen branching enzyme deficiency can be reversed by inhibition of glycogen synthase.
Prenatal diagnosis of glycogen storage disease type IV using PCR-based DNA mutation analysis.
Prenatal diagnosis of glycogen storage disease type IV.
Severe neonatal onset of glycogenosis type IV: clinical and laboratory findings leading to diagnosis in two siblings.
Studies of glycogen branching enzyme. Preparation and properties of -1,4-glucan- -1,4-glucan 6-glycosyltransferase and its action on the characteristic polysaccharide of the liver of children with Type IV glycogen storage disease.
Studies of the residual glycogen branching enzyme activity present in human skin fibroblasts from patients with type IV glycogen storage disease.
Systemic Correction of Murine Glycogen Storage Disease Type IV by an AAV-Mediated Gene Therapy.
The adult polyglucosan body disease mutation GBE1 c.1076A>C occurs at high frequency in persons of Ashkenazi Jewish background.
The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies.
Type IV glycogen storage disease: branching enzyme deficiency in skin fibroblasts and possible heterozygote detection.
Type IV glycogenosis. Patient with absence of a branching enzyme alpha-1,4-glucan:alpha-1,4-glucan 6-glycosyl transferase.
[A study of the abnormal polysaccharide in a child with type IV glycogen storage disease (author's transl)]
[Congenital variant of type IV glycogenosis. Anatomoclinical report of a case]
[Severe cardiomyopathy revealing amylopectinosis. Two cases in adolescents from the same family]
Glycogen Storage Disease Type II
Glycogen storage diseases of muscle.
Glycogen Storage Disease Type IV
A case of congenital glycogen storage disease type IV with a novel GBE1 mutation.
A complex rearrangement in GBE1 causes both perinatal hypoglycemic collapse and late-juvenile-onset neuromuscular degeneration in glycogen storage disease type IV of Norwegian forest cats.
A GYS1 gene mutation is highly associated with polysaccharide storage myopathy in Cob Normand draught horses.
A Modified Enzymatic Method for Measurement of Glycogen Content in Glycogen Storage Disease Type IV.
A new variant of type IV glycogenosis with primary cardiac manifestation and complete branching enzyme deficiency. In vivo detection by heart muscle biopsy.
A new variant of type IV glycogenosis: deficiency of branching enzyme activity without apparent progressive liver disease.
Adult polyglucosan body disease: a rare presentation with chronic liver disease and ground-glass hepatocellular inclusions.
Allele frequency and likely impact of the glycogen branching enzyme deficiency gene in Quarter Horse and Paint Horse populations.
Alteration of mitochondrial function in the livers of mice with glycogen branching enzyme deficiency.
Amylopectinosis disease isolated to the heart with normal glycogen branching enzyme activity and gene sequence.
Association of the Congenital Neuromuscular Form of Glycogen Storage Disease Type IV With a Large Deletion and Recurrent Frameshift Mutation.
Branching enzyme deficiency: expanding the clinical spectrum.
Branching enzyme in erythrocytes. Detection of type IV glycogenosis homozygotes and heterozygotes.
Cardiac Involvement in Glycogen Storage Disease Type IV: Two Cases and the Two Ends of a Spectrum.
Case of Neonatal Fatality from Neuromuscular Variant of Glycogen Storage Disease Type IV.
Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV).
Congenital type IV glycogenosis: the spectrum of pleomorphic polyglucosan bodies in muscle, nerve, and spinal cord with two novel mutations in the GBE1 gene.
Efficient correction of a deleterious point mutation in primary horse fibroblasts with CRISPR-Cas9.
Equine diseases caused by known genetic mutations.
Evaluation of allele frequencies of inherited disease genes in subgroups of American Quarter Horses.
Fatal infantile neuromuscular presentation of glycogen storage disease type IV.
Generation of a novel mouse model that recapitulates early and adult onset glycogenosis type IV.
Genetic mapping of GBE1 and its association with glycogen storage disease IV in American Quarter horses.
Glycogen branching enzyme deficiency in adult polyglucosan body disease.
Glycogen branching enzyme deficiency in an infant with severe congenital hypotonia: an emerging diagnosis of muscle weakness in the perinatal period.
Glycogen branching enzyme deficiency in quarter horse foals.
Glycogen storage disease type IV: a case report.
Glycogen storage disease type IV: inherited deficiency of branching enzyme activity in cats.
Glycogen storage disease type IV: novel mutations and molecular characterization of a heterogeneous disorder.
Hallmarks of oxidative stress in the livers of aged mice with mild glycogen branching enzyme deficiency.
Isolation of human glycogen branching enzyme cDNAs by screening complementation in yeast.
Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).
Living Donor Liver Transplantation in a Korean Child with Glycogen Storage Disease Type IV and a GBE1 Mutation.
Neuromuscular forms of glycogen branching enzyme deficiency.
Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 gene.
Non-lethal congenital hypotonia due to glycogen storage disease type IV.
Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease.
Null mutations and lethal congenital form of glycogen storage disease type IV.
Placental Involvement in Glycogen Storage Disease Type IV.
Polyglucosan neurotoxicity caused by glycogen branching enzyme deficiency can be reversed by inhibition of glycogen synthase.
Prenatal diagnosis of glycogen storage disease type IV using PCR-based DNA mutation analysis.
Prenatal diagnosis of glycogen storage disease type IV.
Structural basis of glycogen branching enzyme deficiency and pharmacologic rescue by rational peptide design.
Systemic Correction of Murine Glycogen Storage Disease Type IV by an AAV-Mediated Gene Therapy.
The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies.
Type IV glycogenosis. Patient with absence of a branching enzyme alpha-1,4-glucan:alpha-1,4-glucan 6-glycosyl transferase.
[Congenital variant of type IV glycogenosis. Anatomoclinical report of a case]
[Glycogen branching enzyme deficiency (Andersen disease)]
[Severe cardiomyopathy revealing amylopectinosis. Two cases in adolescents from the same family]
Glycogen Storage Disease Type V
Glycogen storage diseases of muscle.
Glycogen Storage Disease Type VII
Apparent absence of glycogen branching enzyme activity in phosphofructokinase deficiency.
glycogenin glucosyltransferase deficiency
Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency.
Hearing Loss
A combination of cilostazol and Ginkgo biloba extract protects against cisplatin-induced Cochleo-vestibular dysfunction by inhibiting the mitochondrial apoptotic and ERK pathways.
Ginkgo Biloba Extract Attenuates Oxidative Stress and Apoptosis in Mouse Cochlear Neural Stem Cells.
Ginkgo Biloba Extract Enhances Differentiation and Performance of Neural Stem Cells in Mouse Cochlea.
Heart Failure
Ginkgo biloba Extract Reduces Hippocampus Inflammatory Responses, Improves Cardiac Functions And Depressive Behaviors In A Heart Failure Mouse Model.
Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).
Hydrocephalus
[Effect of Ginkgo biloba extract on neuronal apoptosis in rabbit with kaolin-induced syringomyelia]
Hyperalgesia
Ginkgo biloba extract attenuates hyperalgesia in a rat model of vincristine-induced peripheral neuropathy.
Hyperglycemia
Beneficial effects of Ginkgo biloba extract on insulin signaling cascade, dyslipidemia, and body adiposity of diet-induced obese rats.
Nrf-2 mediated heme oxygenase-1 activation contributes to the anti-inflammatory and renal protective effects of Ginkgo biloba extract in diabetic nephropathy.
Hypertension
Ginkgo biloba extract attenuates the development of hypertension in deoxycorticosterone acetate-salt hypertensive rats.
Long-term feeding of Ginkgo biloba extract impairs peripheral circulation and hepatic function in aged spontaneously hypertensive rats.
Immune System Diseases
Ginkgo biloba extract suppresses endotoxin-mediated monocyte activation by inhibiting nitric oxide- and tristetraprolin-mediated toll-like receptor 4 expression.
Infant, Newborn, Diseases
Genetic mapping of GBE1 and its association with glycogen storage disease IV in American Quarter horses.
Glycogen branching enzyme deficiency in quarter horse foals.
Infarction, Middle Cerebral Artery
[Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof]
Infections
Cholesterol-rich lipid rafts both in cellular and viral membrane are critical for caprine parainfluenza virus type3 entry and infection in host cells.
Coenzyme Q deficiency in mice following infection with Friend leukemia virus.
Insulin Resistance
Ginkgo biloba extract enhances glucose tolerance in hyperinsulinism-induced hepatic cells.
Ischemic Stroke
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline.
Ginkgo biloba extract and its diterpene ginkgolide constituents ameliorate the metabolic disturbances caused by recombinant tissue plasminogen activator in rat prefrontal cortex.
Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
Ginkgol Biloba extract as an adjunctive treatment for ischemic stroke: A systematic review and meta-analysis of randomized clinical trials.
Labyrinthitis
Effect of Ginkgo biloba extract on endotoxin-induced labyrinthitis.
Lafora Disease
Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency.
Liver Cirrhosis
Effect of ginkgo biloba extract on livers in aged rats.
Ginkgo biloba extract alleviates liver fibrosis induced by CCl in rats.
Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-?B/I?B?, and Bcl-2/Bax signaling.
Ginkgo biloba extract reverses CCl4-induced liver fibrosis in rats.
Hepatoprotective effect of ultrasonicated ginseng berry extract on a rat mild bile duct ligation model.
Liver Diseases
A Case of Glycogen Storage Disease IV with Rare Homozygous Mutations in the Glycogen Branching Enzyme Gene.
A new variant of type IV glycogenosis: deficiency of branching enzyme activity without apparent progressive liver disease.
Liver Diseases, Alcoholic
The Edible Insect Gryllus bimaculatus Protects against Gut-Derived Inflammatory Responses and Liver Damage in Mice after Acute Alcohol Exposure.
Liver Failure
A new variant of type IV glycogenosis: deficiency of branching enzyme activity without apparent progressive liver disease.
Low Tension Glaucoma
Ginkgo biloba Extract and Bilberry Anthocyanins Improve Visual Function in Patients with Normal Tension Glaucoma.
Lung Neoplasms
Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity.
Lymphangioma, Cystic
Fetal type IV glycogen storage disease: clinical, enzymatic, and genetic data of a pure muscular form with variable and early antenatal manifestations in the same family.
Lymphoma
Safety evaluation of highly-branched cyclic dextrin and a 1,4-alpha-glucan branching enzyme from Bacillus stearothermophilus.
Memory Disorders
Ginkgo biloba extract improves spatial memory in rats mainly but not exclusively via a histaminergic mechanism.
Protective effect of Ginkgo biloba leaf extract on learning and memory deficit induced by aluminum in model rats.
Metabolic Diseases
Apparent absence of glycogen branching enzyme activity in phosphofructokinase deficiency.
Ginkgo biloba extract improves insulin signaling and attenuates inflammation in retroperitoneal adipose tissue depot of obese rats.
Multiple Sclerosis
Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants.
Muscle Hypotonia
Branching enzyme deficiency/glycogenosis storage disease type IV presenting as a severe congenital hypotonia: Muscle biopsy and autopsy findings, biochemical and molecular genetic studies.
Glycogen branching enzyme deficiency in an infant with severe congenital hypotonia: an emerging diagnosis of muscle weakness in the perinatal period.
Neonatal hypotonia and cardiomyopathy secondary to type IV glycogenosis.
Muscle Weakness
Glycogen branching enzyme deficiency in an infant with severe congenital hypotonia: an emerging diagnosis of muscle weakness in the perinatal period.
Muscular Diseases
A novel missense mutation in the glycogen branching enzyme gene in a child with myopathy and hepatopathy.
Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV).
Equine diseases caused by known genetic mutations.
Evaluation of allele frequencies of inherited disease genes in subgroups of American Quarter Horses.
Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).
Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency.
Myocardial Infarction
Effect of Ginkgo biloba extract on experimental cardiac remodeling.
Myoglobinuria
Glycogen storage diseases of muscle.
Neoplasms
Effects of Ginkgo biloba on chemically-induced mammary tumors in rats receiving tamoxifen.
Enhancement of radiation effect by Ginkgo biloba extract in C3H mouse fibrosarcoma.
Gingko biloba extract reduces VEGF and CXCL-8/IL-8 levels in keratinocytes with cumulative effect with epigallocatechin-3-gallate.
Ginkgo biloba extract inhibits tumor necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells.
Ginkgo biloba extract suppresses endotoxin-mediated monocyte activation by inhibiting nitric oxide- and tristetraprolin-mediated toll-like receptor 4 expression.
Hepatocellular Carcinomas in B6C3F1 Mice Treated with Ginkgo biloba Extract for Two Years Differ from Spontaneous Liver Tumors in Cancer Gene Mutations and Genomic Pathways.
Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells.
The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo.
The histochemically demonstrable phosphorylase and branching enzyme activity in some animals' ascites tumour cells.
Neuroblastoma
Ginkgo biloba extract increases neurite outgrowth and activates the Akt/mTOR pathway.
Ginkgo biloba extract protects human neuroblastoma SH-SY5Y cells against oxidative glutamate toxicity by activating redoxosome-p66Shc.
Neurodegenerative Diseases
Ginkgo biloba extract protects human neuroblastoma SH-SY5Y cells against oxidative glutamate toxicity by activating redoxosome-p66Shc.
Ginkgolide B promotes neuronal differentiation through the Wnt/?-catenin pathway in neural stem cells of the postnatal mammalian subventricular zone.
Neuroinflammatory Diseases
Ginkgo biloba L. extract protects against chronic cerebral hypoperfusion by modulating neuroinflammation and the cholinergic system.
Obesity
Beneficial effects of Ginkgo biloba extract on insulin signaling cascade, dyslipidemia, and body adiposity of diet-induced obese rats.
Ginkgo biloba extract (GbE) attenuates obesity and anxious/depressive-like behaviours induced by ovariectomy.
Ginkgo biloba Extract (GbE) Stimulates the Hypothalamic Serotonergic System and Attenuates Obesity in Ovariectomized Rats.
Ginkgo biloba extract enhances glucose tolerance in hyperinsulinism-induced hepatic cells.
Osteoporosis
Effects of ginkgo biloba on in vitro osteoblast cells and ovariectomized rat osteoclast cells.
Osteoporosis, Postmenopausal
Effects of ginkgo biloba on in vitro osteoblast cells and ovariectomized rat osteoclast cells.
Ototoxicity
[Experimental studies of the protective effect of ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats]
Pancreatic Neoplasms
Phase II study with 5-fluorouracil and ginkgo biloba extract (GBE 761 ONC) in patients with pancreatic cancer.
Paralysis
Equine diseases caused by known genetic mutations.
Evaluation of allele frequencies of inherited disease genes in subgroups of American Quarter Horses.
Paralysis, Hyperkalemic Periodic
Equine diseases caused by known genetic mutations.
Paraplegia
Adult polyglucosan body disease in a patient originally diagnosed with Fabry's disease.
Peripheral Nervous System Diseases
Adult polyglucosan body disease in a patient originally diagnosed with Fabry's disease.
Peripheral Vascular Diseases
Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications.
Pneumothorax
Giant bullous emphysema mistaken for traumatic pneumothorax.
Porphyrias
Glycogen branching enzyme controls cellular iron homeostasis via Iron Regulatory Protein 1 and mitoNEET.
Prostatic Neoplasms
An A/G polymorphism of core 2 branching enzyme gene is associated with prostate cancer.
Pterygium
Whole exome sequencing in foetal akinesia expands the genotype-phenotype spectrum of GBE1 glycogen storage disease mutations.
Relative Energy Deficiency in Sport
Sclerostin/Receptor Related Protein 4 and Ginkgo Biloba Extract Alleviates ?-Glycerophosphate-Induced Vascular Smooth Muscle Cell Calcification By Inhibiting Wnt/?-Catenin Pathway.
Reperfusion Injury
Effects of Gingko biloba extract on gap junction changes induced by reperfusion/reoxygenation after ischemia/hypoxia in rat brain.
The Change of the Spinal Cord Ischemia-Reperfusion Injury in Mitochondrial Passway and the Effect of the Ginkgo biloba Extract's Preconditioning Intervention.
The protective effect of goji berry extract in ischemic reperfusion in testis torsion.
Retinal Diseases
Procyanidin B2 and rutin in Ginkgo biloba extracts protect human retinal pigment epithelial (RPE) cells from oxidative stress by modulating Nrf2 and Erk1/2 signalling.
Rhinitis, Allergic
[Effects of ginkgo biloba extract combined with glucocorticoid on olfactory function and inflammatory cytokines in mice with allergic rhinitis].
ring-type e3 ubiquitin transferase deficiency
Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency.
Severe Combined Immunodeficiency
Equine diseases caused by known genetic mutations.
Skin Diseases
Gingko biloba extract reduces VEGF and CXCL-8/IL-8 levels in keratinocytes with cumulative effect with epigallocatechin-3-gallate.
starch synthase (glycosyl-transferring) deficiency
SSIIIa-RNAi suppression associated changes in rice grain quality and starch biosynthesis metabolism in response to high temperature.
Starvation
Influence of in situ progressive N-terminal is still controversial truncation of glycogen branching enzyme in Escherichia coli DH5? on glycogen structure, accumulation, and bacterial viability.
Stomach Ulcer
Protective effects of Ginkgo biloba extract on the ethanol-induced gastric ulcer in rats.
Stroke
A preclinical randomized controlled study of ischemia treated with Ginkgo biloba extracts: Are complex components beneficial for treating acute stroke?
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline.
Acute but transient neurological deterioration revealing adult polyglucosan body disease.
Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
Pressure segment length analysis of right ventricular function: influence of loading conditions.
The Effects of Game-Based Breathing Exercise on Pulmonary Function in Stroke Patients: A Preliminary Study.
Thyroid Neoplasms
The Effect of Ginkgo biloba Extract on Genotoxic Damage in Patients with Differentiated Thyroid Carcinoma Receiving Thyroid Remnant Ablation with Iodine-131.
Tinnitus
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia.
Ginkgo biloba extract for the treatment of tinnitus.
Tuberculosis
Characterization of the GH13 and GH57 glycogen branching enzymes from Petrotoga mobilis SJ95 and potential role in glycogen biosynthesis.
Crystal structure of full length mycobacterium tuberculosis H37Rv glycogen branching enzyme: Insights of N-terminal {beta}-sandwich in substrate specificity and enzymatic activity.
Discovery of Mycobacterium tuberculosis ?-1,4-glucan branching enzyme (GlgB) inhibitors by structure- and ligand-based virtual screening.
Expression and characterization of alpha-(1,4)-glucan branching enzyme Rv1326c of Mycobacterium tuberculosis H37Rv.
Redox biology of Mycobacterium tuberculosis H37Rv: protein-protein interaction between GlgB and WhiB1 involves exchange of thiol-disulfide.
Uveitis
The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo.
Vascular Diseases
Effects of ginkgo biloba extract on impairment of learning induced by cerebral ischemia in mice.
Vascular System Injuries
Activation of heme oxygenase-1 by Ginkgo biloba extract differentially modulates endothelial and smooth muscle-like progenitor cells for vascular repair.
Vertigo
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia.